Profile
NEUE LH HIMS NVST CON BBNX
Company Name NeueHealth, Inc. Labcorp Holdings Inc. Hims & Hers Health, Inc. Envista Holdings Corp Concentra Group Holdings Parent, Inc. Beta Bionics, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Equipment & Services Medical - Equipment & Services Medical - Equipment & Services Medical - Equipment & Services Medical - Equipment & Services Medical - Equipment & Services
Market Cap $60.94M $24.03B $5.05B $4.78B $2.84B $621.63M
Employees 0.99K 60.90K 1.64K 12.30K 8.76K 0.35K
CEO George Lawrence Mikan III Adam H. Schechter Andrew Dudum Paul A. Keel William Keith Newton Sean T. Saint
Ratings
NEUE LH HIMS NVST CON BBNX
Quant Rating Score 2 3 2 3 2 2
Quant Rating Sell Neutral Sell Neutral Sell Sell
Trading
NEUE LH HIMS NVST CON BBNX
Last Close $6.753 $261.37 $35.58 $19.11 $19.24 $27.16
High 52 $7.54 $290.93 $68.74 $22.33 $23.8 $28.84
Low 52 $3.82 $212.22 $21.79 $14.78 $18.71 $9.71
Price vs. 52 Week High -10.44 % -10.16 % -48.24 % -14.42 % -19.16 % -5.83 %
Price vs. 52 Week Low 76.78 % 23.16 % 63.29 % 29.3 % 2.83 % 179.71 %
Total Return
NEUE LH HIMS NVST CON BBNX
1 Month Return 0 % -8.59 % -28.53 % -4.26 % -3.41 % 35.66 %
3 Month Return 2.79 % -3.37 % -21.09 % -7.95 % -15.87 % 57.36 %
6 Month Return -1.99 % 4.75 % -44.97 % 4.6 % -15.32 % 89.14 %
9 Month Return -7.87 % 6.12 % -39.18 % -13.72 % -17.32 % 24.05 %
YTD Return -8.99 % 13.98 % 47.15 % -0.93 % -2.73 % 0 %
1 Year Return 36.7 % 10.64 % 51.21 % -5.68 % -5.08 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
NEUE LH HIMS NVST CON BBNX
Dividend Yield Percentage (TTM) - 0.99 % - - 1.13 % -
Dividend Paid and Capex Coverage Ration (TTM) -17.02 % 2.72 % 1.68 % 7.98 % 2.3 % -14.31 %
Dividend Per Share (TTM) - 2.88 % - - 0.25 % -
Payout Ratio (TTM) - 28.24 % - - 19.06 % -
Growth
NEUE LH HIMS NVST CON BBNX
Asset Growth -55.58 % 9.89 % 60.37 % -18.99 % - 35.99 %
Gross Profit Growth 18.45 % 7.71 % 64.09 % -4.06 % -100 % 468.93 %
Revenue Growth -19.31 % 6.97 % 69.33 % -2.18 % -100 % 442.93 %
Revenue 3 Year -40.86 % 14.14 % 369.75 % -6.32 % -100 % 28465.39 %
Revenue 5 Year 217.29 % 31.37 % 187.88 % -13.09 % -100 % 28465.39 %
Revenue 10 Year 581.73 % 118.72 % 187.88 % -19.08 % -100 % 28465.39 %
EBIT Growth 86.33 % 51.96 % 310.18 % -52.23 % -100 % -26.22 %
Net Income Growth 88.3 % 78.47 % 635.28 % -1016.37 % 5.69 % -24.17 %
Net Income 3 Yeari Growth Per Share 89.14 % -63.83 % 201.26 % -407.53 % -100 % 33.6 %
Net Income 5 Yeari Growth Per Share -2.17 % 5.67 % 128.15 % -506.59 % -100 % 33.6 %
Net Income 10 Yeari Growth Per Share -104.42 % 47.5 % 128.15 % -469.22 % -100 % 33.6 %
Operating Income Growth 81.38 % 49.77 % 310.18 % -3395.87 % -100 % -26.22 %
Operating Cash Flow Growth (CFG) 95.48 % 19.44 % 241.69 % 22.05 % 1.72 % -48.78 %
Operating 3 Year CFG -243.45 % -41.22 % 731.12 % -12.89 % -100 % 37.05 %
Operating 5 Year CFG -1327.3 % 28.08 % 153.98 % -33.04 % -100 % 37.05 %
Operating 10 Year CFG -333.35 % 116.89 % 153.98 % -27.55 % -100 % 37.05 %
EPS Growth 84.99 % 85.21 % 627.27 % -983.33 % -100 % -3.49 %
EPS Diluted Growth 84.99 % 85.32 % 581.82 % -983.33 % -100 % -3.49 %
Book Value Per Share -46.63 % 6.13 % 34.34 % -31.85 % -100 % 8.07 %
Share Holder 3 Year Equity Growth Per Share -136.26 % -9.66 % 23.23 % -32.29 % -100 % 359.09 %
Share Holder 5 Year Equity Growth Per Share -167.91 % 24.17 % 156.72 % -34.43 % - 359.09 %
Share Holder 10 Year Equity Growth Per Share - 188.55 % 156.72 % - - 359.09 %
Dividend Per Share Growth - -0.64 % - - -100 % -
Dividend 3 Year Growth Per Share - - - - - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - - - - - -
Debt Growth -44.75 % 22.15 % 14.04 % -6.4 % - 71.8 %
Free Cash Flow Growth 95.4 % 25.37 % 322.07 % 39.17 % 32.83 % -57.3 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2025 31 Dec 2024
Profitability
NEUE LH HIMS NVST CON BBNX
Gross Profit Margin TTM 24.21 % 28.45 % 75.01 % 54.75 % 29.08 % 54.51 %
Return on Assets TTM -12.82 % 4.68 % 5.99 % 0.83 % 5.9 % -23.59 %
Return on Equity TTM 21.74 % 10.2 % 24.67 % 1.52 % 51.22 % -31.57 %
Return on Capital Employed TTM 18.12 % 8.53 % 6.45 % 4.48 % 10.44 % -22.52 %
Net Income Per EBT TTM 156.67 % 77.7 % 104.64 % 26.52 % 77.3 % 100 %
EBT Per Ebit TTM 204 % 82.54 % 111.16 % 82 % 82.16 % 113.48 %
EBIT Per Revenue TTM -3.35 % 9.69 % 5.2 % 7.95 % 16.27 % -77.45 %
Cash Flow To Debt Ratio TTM -6994.4 % 27.62 % 29.08 % 18.78 % 11.88 % -736.01 %
Receivables Turnover TTM 2.38 6.08 53.49 6.33 5.82 6.21
Payables Turnover TTM 6.54 14.73 2.78 6.42 35.13 9.03
Inventory Turnover TTM - 18.89 5.21 4.27 - 1.98
Fixed Asset Turnover TTM 7634.09 % 442.22 % 543.59 % 619.62 % 228.31 % 614.69 %
Asset Turnover TTM 119.73 % 75.38 % 99 % 47.89 % 57.12 % 26.84 %
Operating Cash Flow Per Share TTM -7.99 21.7 1.44 1.83 2.01 -1.3
Free Cash Flow Per Share TTM -8.46 16.62 0.58 1.6 1.39 -1.39
Cash Per Share TTM 1663.59 % 719.74 % 278.22 % 737.04 % 39.43 % 524.1 %
Operating Cash Flow Sales Ratio TTM -7.85 % 13.1 % 14.7 % 11.04 % 15.66 % -63.88 %
Free Cash Flow Operating Cash Flow Ratio TTM 105.87 % 76.56 % 40.46 % 87.47 % 69.01 % 106.99 %
Cash Flow Coverage Ratios TTM -6994.4 % 27.62 % 29.08 % 18.78 % 11.88 % -736.01 %
Price To Free Cash Flows Ratio TTM -0.82 17.4 38.37 18.23 16.17 -10.27
Price To Operating Cash Flows Ratio TTM -0.84 13.36 16.03 15.94 11.03 -10.89
Price Cash Flow Ratio TTM -0.84 13.36 16.03 15.94 11.03 -10.89
Income Statement (TTM)
NEUE LH HIMS NVST CON BBNX
Revenue $0.94B $13.01B $1.48B $2.72B $2.16B $0.07B
Gross Profit $0.19B $3.62B $1.17B $1.5B $0B $0.04B
Gross Profit Ratio 20.77% 27.86% 79.45% 55.02% 0% 55.11%
EBITDA $-0.07B $1.81B $0.08B $0.34B $2.16B $-0.04B
Net Income $-0.13B $0.75B $0.13B $0.05B $0.17B $-0.05B
EPS Diluted -22.65 8.84 0.53 0.28 1.37 -8.6
Balance Sheet (MRQ)
NEUE LH HIMS NVST CON BBNX
Long Term Debt $0.2B $6.08B $0.01B $1.56B $1.87B $0.01B
Total Liabilities $0.93B $10.31B $0.23B $2.57B $2.22B $0.07B
Total Equity $-0.39B $8.07B $0.48B $3.11B $0.3B $0.08B
Total Investments $0.01B $0.02B $0.08B $0B $0B $0.07B
Total Debt $0.2B $7.27B $0.01B $1.6B $1.95B $0.01B
Total Assets $0.54B $18.38B $0.71B $5.68B $2.52B $0.15B
Cash Flow Statement (TTM)
NEUE LH HIMS NVST CON BBNX
Net Income $-0.1B $0.75B $0.13B $0.05B $0.17B $-0.05B
Inventory $0B $-0.01B $-0.04B $-0.03B $0B $-0.01B
Dividends Paid $0B $-0.24B $0B $0B $0B $0B
Operating Cash Flow $-0.12B $1.59B $0.25B $0.28B $0.28B $-0.05B
Capital Expenditure $-0B $-0.49B $-0.05B $-0.05B $0B $-0B
Related Stocks
Ticker Name Price
BBNX Beta Bionics, Inc. Common Stock 14.12
CON Concentra Group Holdings Parent, Inc. 24.17
HIMS Hims & Hers Health, Inc. 16.69
KDLY Kindly MD, Inc. Common Stock 11.3
LH Laboratory Corporation of America Holdings 289.89
NAKA KindlyMD, Inc. 0.2683
NVST Envista Holdings Corporation 30.26
PARK Park Dental Partners, Inc. Common Stock 19.25
PFSA Profusa, Inc. Common Stock 2.94
ETFs With Exposure to NEUE
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00005 341.47
VXF Vanguard Extended Market Index Fund 0.00026 218.1
IWC iShares Micro-Cap ETF 0.00528 168.25
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00004 115
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0.00004 114.98
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00006 52.53
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00006 52.52
VBINX Vanguard Balanced Index Fund Investor Shares 0.00006 52.53
VTSAX Vanguard Total Stock Market Index Fund 0.00005 166.24
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00026 165.55
VITSX Vanguard Total Stock Market Index Fund 0.00005 166.27
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00026 165.56
VTS.AX Vanguard US Total Market Shares Index ETF 0.00004 481.52
VEMPX Vanguard Extended Market Index InstlPlus 0.00026 408.54
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00005 311.9
Unlock